Ec-ESBL (N=100) | Ec-MRnoB (N=100) | |||||||
---|---|---|---|---|---|---|---|---|
Agent | Range | MIC50 | MIC90 | %R | Range | MIC50 | MIC90 | %R |
Amoxicillin | 64-≥256 | ≥256 | ≥256 | 100 | 2-≥256 | ≥256 | ≥256 | 99 |
Amoxicillin-Clavulanic acid | 8-16 | 4 | 8 | 41 | 8-≥128 | 8 | 32 | 83 |
Piperacillin | 32-≥64 | ≥64 | ≥64 | 100 | ≤16-≥64 | ≥64 | ≥64 | 84 |
Piperacillin-Tazobactam | ≤0.5-≥256 | 4 | 16 | 16 | ≤0.25-≥256 | 2 | 4 | 6 |
Cefoxitin a | ≤2-32 | ≤2 | 8 | 5 | ≤2-≥32 | 4 | 8 | 8 |
Cefotetan a | ≤1-8 | ≤1 | ≤1 | 0 | ≤1-≥32 | ≤1 | ≤1 | 2 |
Cefotaxime | 32-≥128 | ≥128 | ≥128 | 100 | ≤0.5-128 | ≤0.5 | ≤0.5 | 5 |
Ceftazidime | ≤0.5-≥128 | 2 | 16 | 23 | ≤0.5-128 | ≤0.5 | ≤0.5 | 8 |
Cefepime | ≤1-≥32 | ≥32 | ≥32 | 96 | ≤1-4 | ≤1 | <1 | 1 |
Aztreonam | 2-≥64 | 16 | ≥64 | 96 | ≤0.5-32 | ≤0.5 | ≤0.5 | 6 |
Imipenem | ≤0.5-1 | ≤0.5 | ≤0.5 | 0 | ≤0.5-2 | ≤0.5 | ≤0.5 | 0 |
Meropenem | ≤0.5 | ≤0.5 | ≤0.5 | 0 | ≤0.5 | ≤0.5 | ≤0.5 | 0 |
Gentamicin | ≤0.5-≥256 | 1 | 32 | 19 | 0.5-≥256 | 64 | 256 | 96 |
Tobramycin | 0.5-256 | 1 | 8 | 17 | ≤0.25-256 | 8 | 32 | 89 |
Amikacin | ≤0.5-8 | 2 | 4 | 0 | 1-8 | 2 | 4 | 0 |
Nalidixic acid a | 1-≥256 | ≥256 | ≥256 | 89 | 1-≥256 | ≥256 | ≥256 | 98 |
Ciprofloxacin a | ≤0.5-≥256 | 16 | 128 | 74 | ≤0.25-≥256 | 32 | 128 | 93 |
Tetracycline a | 0.5-≥256 | 256 | 256 | 80 | ≤0.25-256 | 256 | 256 | 84 |
Doxycycline a | ≤0.5-128 | 16 | 64 | 76 | ≤0.25-128 | 32 | 64 | 79 |
Tigecycline b | ≤0.5-1 | ≤0.5 | ≤0.5 | 0 | ≤0.25-0.5 | ≤0.25 | ≤0.25 | 0 |
Trimethoprim-Sulfamethoxazole | ≤0.5-≥32 | ≥32/608 | ≥32/608 | 67 | ≤0.5-≥32 | ≥32/608 | ≥32/608 | 98 |